Urinary bladder tissue engineering using natural scaffolds in a porcine model: Role of toll-like receptors and impact of biomimetic molecules

Cells Tissues Organs

Volumn 192, Issue 4, 2010, Pages 250-261

  Evren, Sevan ^a   Loai, Yasir ^a   Antoon, Roula ^a   Islam, Syed ^a   Yeger, Herman ^a   Moore, Katherine ^a   Wong, Karrie ^b   Gorczynski, Reginald ^b   Farhat, Walid A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiogenesis; Biologic scaffolds; Extracellular matrix; Tissue engineering; Vascular endothelial growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; GAMMA INTERFERON; HYALURONIC ACID; INTERLEUKIN 4; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; UROPLAKIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMIMETICS; BLADDER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE REGENERATION;

ANIMALS; ANTIGENS, CD31; BIOMIMETIC MATERIALS; CYTOKINES; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GUIDED TISSUE REGENERATION; HYALURONIC ACID; INTERFERON-GAMMA; INTERLEUKIN-4; MACROPHAGES; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; TH2 CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; SUS;

EID: 77956707027     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317332     Document Type: Article

References (53)

1. Allman, A.J., T.B. McPherson, S.F. Badylak, L.C. Merrill, B. Kallakury, C. Sheehan, R.H. Raeder, D.W. Metzger (2001) Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 71: 1631-1640.
2. Allman, A.J., T.B. McPherson, L.C. Merrill, S.F. Badylak, D.W. Metzger (2002) The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens. Tissue Eng 8: 53-62.
3. Aoki, K., M. Kurooka, J.J. Chen, J. Petryniak, E.G. Nabel, G.J. Nabel (2001) Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat Immunol 2: 333-337.
4. Atala, A. (2004) Tissue engineering for the replacement of organ function in the genitourinary system. Am J Transplant 4(suppl 6): 58-73.
5. Badylak, S.F., T.W. Gilbert (2008) Immune response to biological scaffold materials. Semin Immunol 20: 109-116.
6. Badylak, S.F., J.E. Valentin, A.K. Ravindra, G.P. McCabe, A.M. Stewart-Akers (2008) Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14: 1835-1842.
7. Baskin, L.S., S.W. Hayward, R.A. Sutherland, M.J. DiSandro, A.A. Thomson, J. Goodman, G.R. Cunha (1996) Mesenchymal-epithelial interactions in the bladder. World J Urol 14: 301-309.
8. Brown, A.L., W. Farhat, P.A. Merguerian, G.J. Wilson, A.E. Khoury, K.A. Woodhouse (2002) 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 23: 2179-2190.
9. Brown, B.N., J.E. Valentin, A.M. Stewart-Akers, G.P. McCabe, S.F. Badylak (2009) Macrophage phenotype and remodeling outcomes in response to biological scaffolds with and without cellular component. Biomaterials 30: 1482-1491.
10. Cartwright, L., W.A. Farhat, C. Sherman, J. Chen, P. Babyn, H. Yeger, H.L. Cheng (2006a) Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A 77: 390-395.
11. Cartwright, L.M., Z. Shou, H. Yeger, W.A. Farhat (2006b) Porcine bladder acellular matrix porosity: impact of hyaluronic acid and lyophilization. J Biomed Mater Res 77: 180-184.
12. Clifford, R.L., K. Deacon, A.J. Knox (2008) Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for smads, (beta)-catenin, and GSK3(beta). J Biol Chem 283: 35337-35353.
13. Faler, B.J., R.A. Macsata, D. Plummer, L. Mishra, A.N. Sidawy (2006) Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther 18: 55-62.
14. Farhat, W., J. Chen, P. Erdeljan, O. Shemtov, D. Courtman, A. Khoury, H. Yeger (2003) Porosity of porcine bladder acellular matrix: impact of ACM thickness. J Biomed Mater Res 67: 970-974.
15. Goldstein, D.R., B.M. Tesar (2004) Toll-like receptors and allograft rejection. Am J Respir Crit Care Med 169: 971; author reply 971-972.
16. Goldstein, D.R., B.M. Tesar, S. Akira, F.G. Lakkis (2003) Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111: 1571-1578.
17. Gulati, A.K., G.P. Cole (1994) Immunogenicity and regenerative potential of acellular nerve allografts to repair peripheral nerve in rats and rabbits. Acta Neurochir 126: 158-164.
18. Hoeben, A., B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, E.A. De Bruijn (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580.
19. Iwasaki, A., R. Medzhitov (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
20. Jennings, J.C., S. Mohan, T.A. Linkhart, R. Widstrom, D.J. Baylink (1988) Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J Cell Physiol 137: 167-172.
21. Khoury, J.M., S.L. Timmons, L. Corbel, G.D. Webster (1992) Complications of enterocystoplasty. Urology 40: 9-14.
22. Kojima, S., S. Hayashi, K. Shimokado, Y. Suzuki, J. Shimada, M.P. Crippa, S.L. Friedman (2000) Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood 95: 1309-1316.
23. Krutzik, S.R., B. Tan, H. Li, M.T. Ochoa, P.T. Liu, S.E. Sharfstein, T.G. Graeber, P.A. Sieling, Y.J. Liu, T.H. Rea, B.R. Bloom, R.L. Modlin (2005) TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11: 653-660.
24. Kulka, M., D.D. Metcalfe (2006) TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 43: 1579-1586.
25. Kulkarni, A.B., C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, S. Karlsson (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774.
26. Land, W.G. (2005) The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79: 505-514.
27. Lawrenson, R., J.J. Wyndaele, I. Vlachonikolis, C. Farmer, S. Glickman (2001) Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 20: 138-143.
28. Li, M., D.F. Carpio, Y. Zheng, P. Bruzzo, V. Singh, F. Ouaaz, R.M. Medzhitov, A.A. Beg (2001) An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135.
29. Libby, P., J.S. Pober (2001) Chronic rejection. Immunity 14: 387-397.
30. McCartney-Francis, N., W. Jin, S.M. Wahl (2004) Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J Immunol 172: 3814-3821.
31. McDougal, W.S. (1992) Metabolic complications of urinary intestinal diversion. J Urol 147: 1199-1208.
32. Medzhitov, R., C. Janeway, Jr. (2000) Innate immune recognition: mechanisms and pathways. Immunol Rev 173 : 89-97.
33. Methe, H., E. Zimmer, C. Grimm, M. Nabauer, J. Koglin (2004) Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 78: 1324-1331.
34. Meyer, S.R., J. Nagendran, L.S. Desai, G.R. Rayat, T.A. Churchill, C.C. Anderson, R.V. Rajotte, J.R. Lakey, D.B. Ross (2005) Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg 130: 469-476.
35. Mou, H.B., M.F. Lin, H. Cen, J. Yu, X.J. Meng (2004) TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression. J Zhejiang Univ Sci 5: 1239-1244.
36. Murphy, W.L., M.C. Peters, D.H. Kohn, D.J. Mooney (2000) Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21: 2521-2527.
37. Netea, M.G., J.W. Van der Meer, R.P. Sutmuller, G.J. Adema, B.J. Kullberg (2005) From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 49: 3991-3996.
38. Ohashi, K., V. Burkart, S. Flohe, H. Kolb (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561.
39. Pelton, R.W., B. Saxena, M. Jones, H.L. Moses, L.I. Gold (1991) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091-1105.
40. Reddy, P.P., D.J. Barrieras, G. Wilson, D.J. Bagli, G.A. McLorie, A.E. Khoury, P.A. Merguerian (2000) Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 164: 936-941.
41. Redecke, V., H. Hacker, S.K. Datta, A. Fermin, P.M. Pitha, D.H. Broide, E. Raz (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743.
42. Rolfe, K.J., J. Richardson, C. Vigor, L.M. Irvine, A.O. Grobbelaar, C. Linge (2007) A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus? J Invest Dermatol 127: 2656-2667.
43. Royaee, A.R., R.J. Husmann, H.D. Dawson, G. Calzada-Nova, W.M. Schnitzlein, F.A. Zu ckermann, J.K. Lunney (2004) Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Vet Immunol Immunopathol 102: 199-216.
44. Saemann, M.D., T. Weichhart, M. Zeyda, G. Staffler, M. Schunn, K.M. Stuhlmeier, Y. Sobanov, T.M. Stulnig, S. Akira, A. von Gabain, U. von Ahsen, W.H. Horl, G.J. Zlabinger (2005) Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475.
45. Samuelsson, P., L. Hang, B. Wullt, H. Irjala, C. Svanborg (2004) Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72: 3179-3186.
46. Schaefer, T.M., K. Desouza, J.V. Fahey, K.W. Beagley, C.R. Wira (2004) Toll-like receptor (TLR) expression and TLR-mediated cytokine/ chemokine production by human uterine epithelial cells. Immunology 112: 428-436.
47. Serrati, S., F. Margheri, M. Pucci, A.R. Cantelmo, R. Cammarota, J. Dotor, F. Borras-Cuesta, G. Fibbi, A. Albini, M. Del Rosso (2009) TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis. Biochem Pharmacol 77: 813-825.
48. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
49. Slevin, M., S. Kumar, J. Gaffney (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 277: 41046-41059.
50. Takeda, K., S. Akira (2005) Toll-like receptors in innate immunity. Int Immunol 17: 1-14.
51. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, J.C. Simon (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111.
52. Valentin, J.E., A.M. Stewart-Akers, T.W. Gilbert, S.F. Badylak (2009) Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15: 1687-1694.
53. Yoshikawa, T., H. Tohyama, T. Katsura, E. Kondo, Y. Kotani, H. Matsumoto, Y. Toyama, K. Yasuda (2006) Effects of local administration of vascular endothelial growth factor on mechanical characteristics of the semitendinosus tendon graft after anterior cruciate ligament reconstruction in sheep. Am J Sports Med 34: 1918-1925.